IL10 and neoplasm: Other studies examining IL-4′s role in prostate cancer suggest that serum IL-4 concentrations are elevated in patients with benign prostatic disease [186], and IL-10 and IL-4′s pro tumor effects likely reflect their immunosuppressive properties.